Regulatory T cells in HIV infection: Can immunotherapy regulate the regulator?

Clinical and Developmental Immunology

Volumn 2012, Issue , 2012, Pages

  Jenabian, Mohammad Ali ^a   Ancuta, Petronela ^b,c   Gilmore, Norbert ^a   Routy, Jean Pierre ^a  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c UNIVERSITY OF MONTREAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

INDOLEAMINE 2,3 DIOXYGENASE INHIBITOR; RECOMBINANT INTERLEUKIN 2; RECOMBINANT INTERLEUKIN 7; IMMUNOLOGIC FACTOR;

ANTIVIRAL THERAPY; CELL INTERACTION; DENDRITIC CELL; DISEASE COURSE; DRUG TARGETING; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTHERAPY; LYMPHOCYTE FUNCTION; LYMPHOCYTE HOMING; LYMPHOID TISSUE; MUCOSAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; TH17 CELL; ANIMAL; CLINICAL TRIAL (TOPIC); IMMUNOLOGY; METHODOLOGY;

ANIMALS; CLINICAL TRIALS AS TOPIC; HIV INFECTIONS; HUMANS; IMMUNOLOGIC FACTORS; IMMUNOTHERAPY; T-LYMPHOCYTES, REGULATORY;

EID: 84867889088     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2012/908314     Document Type: Review

References (135)

1. Chinen T., Volchkov P. Y., Chervonsky A. V., Rudensky A. Y., A critical role for regulatory T cell-mediated control of inflammation in the absence of commensal microbiota. Journal of Experimental Medicine 2010 207 11 2323 2330 2-s2.0-78149310029 10.1084/jem.20101235
2. Baecher-Allan C., Hafler D. A., Human regulatory T cells and their role in autoimmune disease. Immunological Reviews 2006 212 203 216 2-s2.0-33746356813 10.1111/j.0105-2896.2006.00417.x
3. + regulatory T cells. Nature Reviews Immunology 2011 11 2 119 130 2-s2.0-79251500661 10.1038/nri2916
4. Piccirillo C. A., Regulatory T cells in health and disease. Cytokine 2008 43 3 395 401 2-s2.0-51349168951 10.1016/j.cyto.2008.07.469
5. + regulatory T cells in inflammatory bowel disease. Journal of Digestive Diseases 2011 12 4 286 294 2-s2.0-79960705112 10.1111/j.1751-2980.2011.00505.x
6. Sakaguchi S., Sakaguchi N., Asano M., Itoh M., Toda M., Immunologic self-tolerance maintained by activated T cells expressing IL- 2 receptor α -chains (CD25): breakdown of a single mechanism of self- tolerance causes various autoimmune diseases. Journal of Immunology 1995 155 3 1151 1164 2-s2.0-0029150110
7. + CD25high regulatory cells in human peripheral blood. Journal of Immunology 2001 167 3 1245 1253 2-s2.0-0035413350
8. + regulatory T cells. International Immunology 2004 16 11 1643 4656 2-s2.0-8344275995 10.1093/intimm/dxh165
9. + T reg cells. Journal of Experimental Medicine 2006 203 7 1701 1711 2-s2.0-33745817085 10.1084/jem.20060772
10. Seddiki N., Santner-Nanan B., Martinson J., Zaunders J., Sasson S., Landay A., Solomon M., Selby W., Alexander S. I., Nanan R., Kelleher A., De S. G. B. F., Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. Journal of Experimental Medicine 2006 203 7 1693 1700 2-s2.0-33745813929 10.1084/jem.20060468
11. + T cells expressing the FoxP3 transcription factor. Immunity 2009 30 6 899 911 2-s2.0-66949171924 10.1016/j.immuni.2009.03.019
12. + regulatory T cells: more of the same or a division of labor? Immunity 2009 30 5 626 635 2-s2.0-65549123867 10.1016/j.immuni.2009.05.002
13. Haas J., Fritzsching B., Trübswetter P., Korporal M., Milkova L., Fritz B., Vobis D., Krammer P. H., Suri-Payer E., Wildemann B., Prevalence of newly generated naive regulatory T cells (Treg) is critical for Treg suppressive function and determines T reg dysfunction in multiple sclerosis. Journal of Immunology 2007 179 2 1322 1330 2-s2.0-34548721641
14. + regulatory T cells. Journal of Immunology 2004 172 10 5986 5993 2-s2.0-2442450433
15. Weiner H. L., Induction and mechanism of action of transforming growth factor- β -secreting Th3 regulatory cells. Immunological Reviews 2001 182 207 214 2-s2.0-0035186416 10.1034/j.1600-065X.2001.1820117.x
16. Deaglio S., Dwyer K. M., Gao W., Friedman D., Usheva A., Erat A., Chen J. F., Enjyoji K., Linden J., Oukka M., Kuchroo V. K., Strom T. B., Robson S. C., Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. Journal of Experimental Medicine 2007 204 6 1257 1265 2-s2.0-34250351459 10.1084/jem.20062512
17. Mucida D., Park Y., Kim G., Turovskaya O., Scott I., Kronenberg M., Cheroutre H., Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science 2007 317 5835 256 260 2-s2.0-34447503805 10.1126/science.1145697
18. Strisciuglio C., van Deventer S., Regulatory T cells as potential targets for immunotherapy in inflammatory bowel disease. Immunotherapy 2010 2 6 749 752 2-s2.0-78649511214 10.2217/imt.10.63
19. Lu Y., Giver C.R., Sharma A., IFN-gamma and indoleamine 2, 3-dioxygenase signaling between donor dendritic cells and T cells regulates graft versus host and graft versus leukemia activity. Blood 2012 119 4 1075 1085 10.1182/blood-2010-12-322891
20. Wei S., Kryczek I., Zou W., Regulatory T-cell compartmentalization and trafficking. Blood 2006 108 2 426 431 2-s2.0-33745968543 10.1182/blood-2006-01- 0177
21. + regulatory T cells results in tissue-specific inflammatory disease. Journal of Experimental Medicine 2007 204 6 1335 1347 2-s2.0-34250336452 10.1084/jem.20070081
22. + regulatory T cells in the small intestinal lamina propria show an effector/memory phenotype. International Immunology 2008 20 3 307 315 2-s2.0-40049110259 10.1093/intimm/dxm143
23. + T cells undergo conventional first switch to lymphoid tissue homing receptors in thymus but accelerated second switch to nonlymphoid tissue homing receptors in secondary lymphoid tissues. Journal of Immunology 2007 178 1 301 311 2-s2.0-33845944537
24. Rosenblum M. D., Gratz I. K., Paw J. S., Response to self antigen imprints regulatory memory in tissues. Nature 2011 480 7378 538 542 10.1038/nature10664
25. Yang X. O., Nurieva R., Martinez G. J., Kang H. S., Chung Y., Pappu B. P., Shah B., Chang S. H., Schluns K. S., Watowich S. S., Feng X. H., Jetten A. M., Dong C., Molecular antagonism and plasticity of regulatory and inflammatory T cell programs. Immunity 2008 29 1 44 56 2-s2.0-46749138596 10.1016/j.immuni.2008.05.007
26. + T cell suppressor function. European Journal of Immunology 2004 34 2 366 376 2-s2.0-1642390941 10.1002/eji.200324455
27. + Treg cells: hydrolysis of extracellular ATP and immune suppression. Blood 2007 110 4 1225 1232 2-s2.0-34547098277 10.1182/blood-2006-12-064527
28. + Treg cells. Journal of Biological Regulators and Homeostatic Agents 2010 24 2 131 135 2-s2.0-77955857307
29. + effector T cells with high inflammatory potential and a strong bias for secretion of interleukin 10. Journal of Experimental Medicine 2003 197 2 181 193 2-s2.0-0037455003 10.1084/jem.20020632
30. Burmeister Y., Lischke T., Dahler A. C., Mages H. W., Lam K. P., Coyle A. J., Kroczek R. A., Hutloff A., ICOS controls the pool size of effector-memory and regulatory T cells. Journal of Immunology 2008 180 2 774 782 2-s2.0-40449116396
31. + T-cell population with regulatory activity. European Journal of Immunology 2011 41 8 2269 2278 2-s2.0-79960718028 10.1002/eji.201040943
32. Libera D. D., Di Mitri D., Bergami A., Centonze D., Gasperini C., Grasso M. G., Galgani S., Martinelli V., Comi G., Avolio C., Martino G., Borsellino G., Sallusto F., Battistini L., Furlan R., T regulatory cells are markers of disease activity in multiple sclerosis patients. PLoS ONE 2011 6 6 2-s2.0-79959770302 10.1371/journal.pone.0021386 e21386
33. Alexander C. M., Tygrett L. T., Boyden A. W., Wolniak K. L., Legge K. L., Waldschmidt T. J., T regulatory cells participate in the control of germinal centre reactions. Immunology 2011 133 4 452 468 2-s2.0-79959905757 10.1111/j.1365-2567.2011.03456.x
34. Zanin-Zhorov A., Ding Y., Kumari S., Protein kinase C- θ mediates negative feedback on regulatory T cell function. Science 2010 328 5976 372 376 10.1126/science.1186068
35. Sarris M., Betz A. G., Live imaging of dendritic cell-Treg cell interactions. Methods in Molecular Biology 2011 707 83 101 2-s2.0-79955699753 10.1007/978-1-61737-979-67
36. + regulatory T cell function. Science 2008 322 5899 271 275 2-s2.0-53749094183 10.1126/science.1160062
37. Hryniewicz A., Boasso A., Edghill-Smith Y., CTLA-4 blockade decreases TGF- β IDO, and viral RNA expression in tissues of SIVmac251-infected macaques. Blood 2006 108 12 3834 3842 10.1182/blood-2006-04-010637
38. Cao X., Cai S. F., Fehniger T. A., Song J., Collins L. I., Piwnica-Worms D. R., Ley T. J., Granzyme B and perforin are important for regulatory T cell-mediated suppression of tumor clearance. Immunity 2007 27 4 635 646 2-s2.0-35449006679 10.1016/j.immuni.2007.08.014
39. Loebbermann J., Thornton H., Durant L., Regulatory T cells expressing granzyme B play a critical role in controlling lung inflammation during acute viral infection. Mucosal Immunology 2012 5 2 161 172 10.1038/mi.2011.62
40. Ohta A., Sitkovsky M., Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage. Nature 2001 414 6866 916 920 2-s2.0-0035924320 10.1038/414916a
41. Sitkovsky M. V., Lukashev D., Apasov S., Kojima H., Koshiba M., Caldwell C., Ohta A., Thiel M., Physiological control of immune response and inflammatory tissue damage by hypoxia-inducible factors and adenosine A2A receptors. Annual Review of Immunology 2004 22 657 682 2-s2.0-2542432162 10.1146/annurev.immunol. 22.012703.104731
42. Ohta A., Ohta A., Madasu M., Kini R., Subramanian M., Goel N., Sitkovsky M., A2A adenosine receptor may allow expansion of T cells lacking effector functions in extracellular adenosine-rich microenvironments. Journal of Immunology 2009 183 9 5487 5493 2-s2.0-77950249826 10.4049/jimmunol.0901247
43. Bettelli E., Dastrange M., Oukka M., Foxp3 interacts with nuclear factor of activated T cells and NF- κ B to repress cytokine gene expression and effector functions of T helper cells. Proceedings of the National Academy of Sciences of the United States of America 2005 102 14 5138 5143 2-s2.0-17044393922 10.1073/pnas.0501675102
44. Sakaguchi S., Yamaguchi T., Nomura T., Ono M., Regulatory T cells and immune tolerance. Cell 2008 133 5 775 787 2-s2.0-43949105866 10.1016/j.cell.2008.05.009
45. Wu Y., Borde M., Heissmeyer V., Feuerer M., Lapan A. D., Stroud J. C., Bates D. L., Guo L., Han A., Ziegler S. F., Mathis D., Benoist C., Chen L., Rao A., FOXP3 controls regulatory T cell function through cooperation with NFAT. Cell 2006 126 2 375 387 2-s2.0-33746228122 10.1016/j.cell.2006.05.042
46. + T cells infiltrate the target tissue in experimental autoimmunity. Journal of Immunology 2010 185 12 7467 7473 2-s2.0-78650655423 10.4049/jimmunol.1001519
47. + regulatory T-cell homeostasis via hypoxia-inducible factor-1 α European Journal of Immunology 2008 38 9 2412 2418 2-s2.0-55249095393 10.1002/eji.200838318
48. Dang E. V., Barbi J., Yang H. Y., Control of T(H)17/T(reg) balance by hypoxia-inducible factor 1. Cell 2011 146 5 772 784 10.1016/j.cell.2011.07.033
49. Shi L. Z., Wang R., Huang G., Vogel P., Neale G., Green D. R., Chi H., HIF1 α -dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells. Journal of Experimental Medicine 2011 208 7 1367 1376 2-s2.0-79960369458 10.1084/jem.20110278
50. Koup R. A., Safrit J. T., Cao Y., Andrews C. A., McLeod G., Borkowsky W., Farthing C., Ho D. D., Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. Journal of Virology 1994 68 7 4650 4655 2-s2.0-0028337166
51. + T cells leads to reversible immune dysfunction. Nature Medicine 2006 12 10 1198 1202 2-s2.0-33749009709 10.1038/nm1482
52. + T-cell pool, immune activation, and inflammation. Topics in HIV Medicine 2010 18 1 2 6 2-s2.0-77952540443
53. + regulatory t cells from the intestinal lamina propria but not peripheral blood or lymph nodes during acute simian immunodeficiency virus infection. Journal of Virology 2007 81 23 12748 12757 2-s2.0-36349005400 10.1128/JVI.00841-07
54. Genesca M., Ma Z. M., Wang Y., Live-attenuated lentivirus immunization modulates innate immunity and inflammation while protecting RM from vaginal SIV challenge. Journal of Virology 2012 86 17 9188 9200
55. Bluestone J. A., The Yin and Yang of interleukin-2mediated immunotherapy. The New England Journal of Medicine 2011 365 22 2129 2131 2-s2.0-82555192217
56. Moreno-Fernandez M. E., Presicce P., Chougnet C. A., Homeostasis and function of regulatory T cells in HIV/SIV infection. Journal of Virology 2012 86 19 10262 10269
57. Presicce P., Orsborn K., King E., Pratt J., Fichtenbaum C. J., Chougnet C. A., Frequency of circulating regulatory T cells increases during chronic HIV infection and is largely controlled by highly active antiretroviral therapy. PLoS ONE 2011 6 12 e28118 2-s2.0-82655183583 10.1371/journal.pone.0028118
58. + Treg in HIV-1-infected patients with low CD4 counts. European Journal of Immunology 2009 39 1 301 309 2-s2.0-60549090886 10.1002/eji.200838667
59. Kared H., Lelièvre J. D., Donkova-Petrini V., Aouba A., Melica G., Balbo M., Weiss L., Lévy Y., HIV-specific regulatory T cells are associated with higher CD4 cell counts in primary infection. AIDS 2008 22 18 2451 2460 2-s2.0-57349175888 10.1097/QAD.0b013e328319edc0
60. + regulatory T cells, which suppress HIV-specific CD4 T-cell responses in HIV-infected patients. Blood 2004 104 10 3249 3256 2-s2.0-8644280556 10.1182/blood-2004-01-0365
61. Shaw J. M., Hunt P. W., Critchfield J. W., McConnell D. H., Garcia J. C., Pollard R. B., Somsouk M., Deeks S. G., Shacklett B. L., Increased frequency of regulatory t cells accompanies increased immune activation in rectal mucosae of HIV-positive noncontrollers. Journal of Virology 2011 85 21 11422 11434 2-s2.0-80055115449 10.1128/JVI.05608-11
62. + regulatory T cells control T-cell responses to human immunodeficiency virus and cytomegalovirus antigens. Journal of Virology 2004 78 5 2454 2459 2-s2.0-10744227590 10.1128/JVI.78.5.2454-2459. 2004
63. + HIV-specific T cell immune responses in vitro and are associated with favorable clinical markers of disease status. Journal of Experimental Medicine 2004 200 3 331 343 2-s2.0-3543098686 10.1084/jem.20032069
64. + regulatory T cells in HIV-infected patients with low-level CD4 T-cell repopulation despite suppressive highly active antiretroviral therapy. Journal of Infectious Diseases 2012 205 10 1501 1509 10.1093/infdis/jis230
65. Nikolova M., Carriere M., Jenabian M. A., Limou S., Younas M., Kök A., Huë S., Seddiki N., Hulin A., Delaneau O., Schuitemaker H., Herbeck J. T., Mullins J. I., Muhtarova M., Bensussan A., Zagury J. F., Lelievre J. D., Lévy Y., CD39/adenosine pathway is involved in AIDS progression. PLoS Pathogens 2011 7 7 2-s2.0-79960931448 10.1371/journal.ppat.1002110 e1002110
66. + T regulatory cells correlates with progressive disease. Journal of Virology 2011 85 3 1287 1297 2-s2.0-78651396992 10.1128/JVI.01758-10
67. Jenabian M. A., Yatim A., Carriere M., Effect of the CD39/Adenosine enzymatic pathway on the inhibitory effect of regulatory T cells (Treg) through suppression of IL-2 production in HIV-1 infection. Proceedings of the 19th Conference on Retroviruses and Opportunistic Infections 2012 Seattle, Wash, USA
68. Belkaid Y., Rouse B. T., Natural regulatory T cells in infectious disease. Nature Immunology 2005 6 4 353 360 2-s2.0-16844369607 10.1038/ni1181
69. de St Groth B. F., Landay A. L., Regulatory T cells in HIV infection: pathogenic or protective participants in the immune response? AIDS 2008 22 6 671 683 2-s2.0-41349101159 10.1097/QAD.0b013e3282f466da
70. Moreno-Fernandez M. E., Rueda C. M., Rusie L. K., Chougnet C. A., Regulatory T cells control HIV replication in activated T cells through a cAMP-dependent mechanism. Blood 2011 117 20 5372 5380 2-s2.0-79956339815 10.1182/blood-2010-12-323162
71. + regulatory T cells. Journal of Infectious Diseases 2009 199 9 1318 1322 2-s2.0-65649106139 10.1086/597801
72. Brandt L., Benfield T., Mens H., Clausen L. N., Katzenstein T. L., Fomsgaard A., Karlsson I., Low level of regulatory T cells and maintenance of balance between regulatory T cells and TH17 cells in HIV-1-infected elite controllers. Journal of Acquired Immune Deficiency Syndromes 2011 57 2 101 108 2-s2.0-79957940672 10.1097/QAI.0b013e318215a991
73. + regulatory T cells in HIV-exposed seronegative persons and HIV-infected persons with different disease progressions. Viral Immunology 2011 24 1 57 60 2-s2.0-79951797419 10.1089/vim.2010.0079
74. Hunt P. W., Landay A. L., Sinclair E., Martinson J. A., Hatano H., Emu B., Norris P. J., Busch M. P., Martin J. N., Brooks C., McCune J. M., Deeks S. G., A low T regulatory cell response may contribute to both viral control and generalized immune activation in HIV controllers. PLoS ONE 2011 6 1 2-s2.0-79551649723 10.1371/journal.pone.0015924 e15924
75. Angin M., Kwon D. S., Streeck H., Wen F., King M., Rezai A., Law K., Hongo T. C., Pyo A., Piechocka-Trocha A., Toth I., Pereyra F., Ghebremichael M., Rodig S. J., Milner Jr. D. A., Richter J. M., Altfeld M., Kaufmann D. E., Walker B. D., Addo M. M., Preserved function of regulatory T cells in chronic HIV-1 infection despite decreased numbers in blood and tissue. Journal of Infectious Diseases 2012 205 10 1495 1500 2-s2.0-84860359331 10.1093/infdis/jis236
76. + T cells evade T reg cell suppression. Nature Medicine 2011 17 8 989 995 2-s2.0-79961160736 10.1038/nm.2422
77. Ancuta P., Monteiro P., Sekaly R. P., Th17 lineage commitment and HIV-1 pathogenesis. Current Opinion in HIV and AIDS 2010 5 2 158 165 2-s2.0-76949097773 10.1097/COH.0b013e3283364733
78. Quintana F. J., Basso A. S., Iglesias A. H., Korn T., Farez M. F., Bettelli E., Caccamo M., Oukka M., Weiner H. L., Control of Treg and TH17 cell differentiation by the aryl hydrocarbon receptor. Nature 2008 453 7191 65 71 2-s2.0-42649095378 10.1038/nature06880
79. Chege D., Sheth P. M., Kain T., Kim C. J., Kovacs C., Loutfy M., Halpenny R., Kandel G., Chun T. W., Ostrowski M., Kaul R., Yi T. J., Huibner S., Mujib S., Persad D., Benko E., Sigmoid Th17 populations, the HIV latent reservoir, and microbial translocation in men on long-term antiretroviral therapy. AIDS 2011 25 6 741 749 2-s2.0-79953735335 10.1097/QAD.0b013e328344cefb
80. Brenchley J. M., Price D. A., Schacker T. W., Asher T. E., Silvestri G., Rao S., Kazzaz Z., Bornstein E., Lambotte O., Altmann D., Blazar B. R., Rodriguez B., Teixeira-Johnson L., Landay A., Martin J. N., Hecht F. M., Picker L. J., Lederman M. M., Deeks S. G., Douek D. C., Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nature Medicine 2006 12 12 1365 1371 2-s2.0-33845532053 10.1038/nm1511
81. Kanwar B., Favre D., McCune J. M., Th17 and regulatory T cells: implications for AIDS pathogenesis. Current Opinion in HIV and AIDS 2010 5 2 151 157 2-s2.0-76949108202 10.1097/COH.0b013e328335c0c1
82. de Luca A., Montagnoli C., Zelante T., Bonifazi P., Bozza S., Moretti S., D'Angelo C., Vacca C., Boon L., Bistoni F., Puccetti P., Fallarino F., Romani L., Functional yet balanced reactivity to Candida albicans requires TRIF, MyD88, and IDO-dependent inhibition of Rorc. Journal of Immunology 2007 179 9 5999 6008 2-s2.0-37349076668
83. + T helper cells. Cell 2006 126 6 1121 1133 2-s2.0-33748588423 10.1016/j.cell.2006.07.035
84. Romani L., Fallarino F., de Luca A., Montagnoli C., D'Angelo C., Zelante T., Vacca C., Bistoni F., Fioretti M. C., Grohmann U., Segal B. H., Puccetti P., Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease. Nature 2008 451 7175 211 215 2-s2.0-38049115134 10.1038/nature06471
85. Romani L., Zelante T., de Luca A., Fallarino F., Puccetti P., IL-17 and therapeutic kynurenines in pathogenic inflammation to fungi. Journal of Immunology 2008 180 8 5157 5162 2-s2.0-45949104818
86. Baban B., Chandler P. R., Sharma M. D., Pihkala J., Koni P. A., Munn D. H., Mellor A. L., IDO activates regulatory T cells and blocks their conversion into Th17-like T cells. Journal of Immunology 2009 183 4 2475 2483 2-s2.0-70149101645 10.4049/jimmunol.0900986
87. + Tregs to TH17-like cells in tumor-draining lymph nodes. Blood 2009 113 24 6102 6111 2-s2.0-67650351923 10.1182/blood-2008-12-195354
88. Zelante T., Fallarino F., Bistoni F., Puccetti P., Romani L., Indoleamine 2,3-dioxygenase in infection: the paradox of an evasive strategy that benefits the host. Microbes and Infection 2009 11 1 133 141 2-s2.0-58249103970 10.1016/j.micinf.2008.10.007
89. Favre D., Mold J., Hunt P. W., Kanwar B., Loke P., Seu L., Barbour J. D., Lowe M. M., Jayawardene A., Aweeka F., Huang Y., Douek D. C., Brenchley J. M., Martin J. N., Hecht F. M., Deeks S. G., McCune J. M., Tryptophan catabolism by indoleamine 2,3-dioxygenase 1 alters the balance of TH17 to regulatory T cells in HIV disease. Science Translational Medicine 2010 2 32 32ra36 2-s2.0-77952977625 10.1126/scitranslmed.3000632
90. Favre D., Lederer S., Kanwar B., Ma Z. M., Proll S., Kasakow Z., Mold J., Swainson L., Barbour J. D., Baskin C. R., Palermo R., Pandrea I., Miller C. J., Katze M. G., McCune J. M., Critical loss of the balance between Th17 and T regulatory cell populations in pathogenic SIV infection. PLoS Pathogens 2009 5 2 2-s2.0-61449115882 10.1371/journal.ppat.1000295 e1000295
91. Patel M., Jenabian M. A., Lebouché B., Elite conrollers show a unique Tryptophan immunosuppressive catabolism. Proceedings of the 19th International AIDS Conference 2012 Washington DC, USA
92. +CD25high regulatory T cells and programmed death-ligand 1 in chronic hepatitis B. Viral Immunology 2012 25 1 21 28 2-s2.0-84863011093 10.1089/vim.2011.0049
93. Weiss L., Piketty C., Assoumou L., Didier C., Caccavelli L., Donkova-Petrini V., Levy Y., Girard P. M., Burgard M., Viard J. P., Rouzioux C., Costagliola D., Relationship between regulatory T cells and immune activation in human immunodeficiency virus-infected patients interrupting antiretroviral therapy. PLoS ONE 2010 5 7 2-s2.0-77955351656 10.1371/journal.pone.0011659 e11659
94. Brenchley J. M., Paiardini M., Knox K. S., Asher A. I., Cervasi B., Asher T. E., Scheinberg P., Price D. A., Hage C. A., Kholi L. M., Khoruts A., Frank I., Else J., Schacker T., Silvestri G., Douek D. C., Differential Th17 CD4 T-cell depletion in pathogenic and nonpathogenic lentiviral infections. Blood 2008 112 7 2826 2835 2-s2.0-53449093632 10.1182/blood-2008-05-159301
95. + T-cell restoration in gut-associated lymphoid tissue of HIV-infected patients is associated with enhanced Th17 cells and polyfunctional HIV-specific T-cell responses. Mucosal Immunology 2008 1 6 475 488 2-s2.0-54449084622 10.1038/mi.2008.35
96. Curran M. A., Montalvo W., Yagita H., Allison J. P., PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors. Proceedings of the National Academy of Sciences of the United States of America 2010 107 9 4275 4280 2-s2.0-77749279776 10.1073/pnas.0915174107
97. + Tregs by limiting STAT-5 phosphorylation in patients chronically infected with HCV. Journal of Clinical Investigation 2009 119 3 551 564 2-s2.0-65649139622 10.1172/JCI36604
98. Ni L., Ma C. J., Zhang Y., Nandakumar S., Zhang C. L., Wu X. Y., Borthwick T., Hamati A., Chen X. Y., Kumaraguru U., Moorman J. P., Yao Z. Q., PD-1 modulates regulatory T cells and suppresses T-cell responses in HCV-associated lymphoma. Immunology and Cell Biology 2011 89 4 535 539 2-s2.0-79955783905 10.1038/icb.2010.121
99. Day C. L., Kaufmann D. E., Kiepiela P., Brown J. A., Moodley E. S., Reddy S., Mackey E. W., Miller J. D., Leslie A. J., DePierres C., Mncube Z., Duraiswamy J., Zhu B., Eichbaum Q., Altfeld M., Wherry E. J., Coovadia H. M., Goulder P. J. R., Klenerman P., Ahmed R., Freeman G. J., Walker B. D., PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 2006 443 7109 350 354 2-s2.0-33748947326 10.1038/nature05115
100. + T cell activation during HIV infection. Nature Medicine 2010 16 4 452 459 2-s2.0-77950525439 10.1038/nm.2106
101. Rueda C. M., Velilla P. A., Chougnet C. A., Montoya C. J., Rugeles M. T., HIV-induced T-cell activation/exhaustion in rectal mucosa is controlled only partially by antiretroviral treatment. PLoS ONE 2012 7 1 Article numbere30307 2-s2.0-84856016549 10.1371/journal.pone.0030307
102. Amarnath S., Costanzo C. M., Mariotti J., Ullman J. L., Telford W. G., Kapoor V., Riley J. L., Levine B. L., June C. H., Fong T., Warner N. L., Fowler D. H., Regulatory T cells and human myeloid dendritic cells promote tolerance via programmed death ligand-1. PLoS Biology 2010 8 2 2-s2.0-77649163290 10.1371/journal.pbio.1000302 e1000302
103. Amarnath S., Mangus C. W., Wang J. C. M., The PDL1-PD1 axis converts human TH1 cells into regulatory T cells. Science Translational Medicine 2011 3 111 111ra120 10.1126/scitranslmed.3003130
104. + follicular regulatory T cells control the germinal center response. Nature Medicine 2011 17 8 975 982 2-s2.0-79961151137 10.1038/nm.2425
105. Munn D. H., Blocking IDO activity to enhance anti-tumor immunity. Frontiers in Bioscience (Elite Edition) 2012 4 734 745
106. Opitz C. A., Litzenburger U. M., Opitz U., Sahm F., Ochs K., Lutz C., Wick W., Platten M., The indoleamine-2,3-dioxygenase (IDO) inhibitor 1-methyl-d-tryptophan upregulates IDO1 in human cancer cells. PLoS ONE 2011 6 5 2-s2.0-79956302084 10.1371/journal.pone.0019823 e19823
107. Potula R., Poluektova L., Knipe B., Chrastil J., Heilman D., Dou H., Takikawa O., Munn D. H., Gendelman H. E., Persidsky Y., Inhibition of indoleamine 2,3-dioxygenase (IDO) enhances elimination of virus-infected macrophages in an animal model of HIV-1 encephalitis. Blood 2005 106 7 2382 2390 2-s2.0-27144489077 10.1182/blood-2005-04-1403
108. Boasso A., Vaccari M., Fuchs D., Hardy A. W., Tsai W. P., Tryniszewska E., Shearer G. M., Franchini G., Combined effect of antiretroviral therapy and blockade of IDO in SIV-infected rhesus macaques. Journal of Immunology 2009 182 7 4313 4320 2-s2.0-64249110601 10.4049/jimmunol.0803314
109. Vaccari M., Boasso A., Fenizia C., Fuchs D., Hryniewicz A., Morgan T., Weiss D., Doster M. N., Heraud J. M., Shearer G. M., Franchini G., Fatal pancreatitis in simian immunodeficiency virus SIVmac251-infected macaques treated with 2′3′-dideoxyinosine and stavudine following cytotoxic-T-lymphocyte-associated antigen 4 and indoleamine 2,3-dioxygenase blockade. Journal of Virology 2012 86 1 108 113 2-s2.0-84855959941 10.1128/JVI.05609-11
110. García F., Routy J. P., Challenges in dendritic cells-based therapeutic vaccination in HIV-1 infection. Workshop in dendritic cell-based vaccine clinical trials in HIV-1. Vaccine 2011 29 38 6454 6463 2-s2.0-79960865428 10.1016/j.vaccine.2011.07.043
111. Lu W., Wu X., Lu Y., Guo W., Andrieu J. M., Therapeutic dendritic-cell vaccine for simian aids. Nature Medicine 2003 9 1 27 32 2-s2.0-0037234103 10.1038/nm806
112. Lu W., Arraes L. C., Ferreira W. T., Andrieu J. M., Therapeutic dendritic-cell vaccine for chronic HIV-1 infection. Nature Medicine 2004 10 12 1359 1365 2-s2.0-11144283687 10.1038/nm1147
113. Routy J. P., Boulassel M. R., Yassine-Diab B., Nicolette C., Healey D., Jain R., Landry C., Yegorov O., Tcherepanova I., Monesmith T., Finke L., Sékaly R. P., Immunologic activity and safety of autologous HIV RNA-electroporated dendritic cells in HIV-1 infected patients receiving antiretroviral therapy. Clinical Immunology 2010 134 2 140 147 2-s2.0-73549125003 10.1016/j.clim.2009.09.009
114. Liao W., Lin J. X., Wang L., Li P., Leonard W. J., Modulation of cytokine receptors by IL-2 broadly regulates differentiation into helper T cell lineages. Nature Immunology 2011 12 6 551 559 2-s2.0-79956085895 10.1038/ni.2030
115. Malek T. R., The biology of interleukin-2. Annual Review of Immunology 2008 26 453 479 2-s2.0-41949097030 10.1146/annurev.immunol.26.021607.090357
116. Yang X. P., Ghoreschi K., Steward-Tharp S. M., Rodriguez-Canales J., Zhu J., Grainger J. R., Hirahara K., Sun H. W., Wei L., Vahedi G., Kanno Y., O'Shea J. J., Laurence A., Opposing regulation of the locus encoding IL-17 through direct, reciprocal actions of STAT3 and STAT5. Nature Immunology 2011 12 3 247 254 2-s2.0-79951682333 10.1038/ni.1995
117. Cheng G., Yu A., Malek T. R., T-cell tolerance and the multi-functional role of IL-2R signaling in T-regulatory cells. Immunological Reviews 2011 241 1 63 76 2-s2.0-79954559096 10.1111/j.1600-065X.2011.01004.x
118. Malek T. R., Yu A., Vincek V., Scibelli P., Kong L., CD4 regulatory T cells prevent lethal autoimmunity in IL-2R β -deficient mice: implications for the nonredundant function of IL-2. Immunity 2002 17 2 167 178 2-s2.0-0036669298 10.1016/S1074-7613(02)00367-9
119. Xue H. H., Kovanen P. E., Pise-Masison C. A., Berg M., Radovich M. F., Brady J. N., Leonard W. J., Il-2 negatively regulates IL-7 receptor α chain expression in activated T lymphocytes. Proceedings of the National Academy of Sciences of the United States of America 2002 99 21 13759 13764 2-s2.0-0037109077 10.1073/pnas.212214999
120. + T cells: evidence for two distinct regulatory mechanisms. European Journal of Immunology 2001 31 6 1637 1645 2-s2.0-0034965185 10.1002/1521-4141(200106)31:61637::AID-IMMU1637>3.0.CO;2-T
121. Czystowska M., Strauss L., Bergmann C., Szajnik M., Rabinowich H., Whiteside T. L., Reciprocal granzyme/perforin-mediated death of human regulatory and responder T cells is regulated by interleukin-2 (IL-2). Journal of Molecular Medicine 2010 88 6 577 588 2-s2.0-77954564039 10.1007/s00109-010-0602- 9
122. Abrams D., Lévy Y., Losso M. H., Babiker A., Collins G., Cooper D. A., Darbyshire J., Emery S., Fox L., Gordin F., Lane H. C., Lundgren J. D., Mitsuyasu R., Neaton J. D., Phillips A., Routy J. P., Tambussi G., Wentworth D., Interleukin-2 therapy in patients with HIV infection. The New England Journal of Medicine 2009 361 16 1548 1559 2-s2.0-74849114986 10.1056/NEJMoa0903175
123. + regulatory T cell populations in interleukin-2-treated HIV patients. Proceedings of the National Academy of Sciences of the United States of America 2010 107 23 10632 10637 2-s2.0-77953748800 10.1073/pnas.1000027107
124. Saadoun D., Rosenzwajg M., Joly F., Six A., Carrat F., Thibault V., Sene D., Cacoub P., Klatzmann D., Regulatory T-cell responses to low-dose interleukin-2 in HCV-induced vasculitis. The New England Journal of Medicine 2011 365 22 2067 2077 2-s2.0-82555196118
125. Beq S., Rozlan S., Gautier D., Parker R., Mersseman V., Schilte C., Assouline B., Rancé I., Lavedan P., Morre M., Cheynier R., Injection of glycosylated recombinant simian IL-7 provokes rapid and massive T-cell homing in rhesus macaques. Blood 2009 114 4 816 825 2-s2.0-68249151155 10.1182/blood-2008-11-191288
126. Levy Y., Lacabaratz C., Weiss L., Viard J. P., Goujard C., Lelièvre J. D., Boué F., Molina J. M., Rouzioux C., Avettand-Fénoêl V., Croughs T., Beq S., Thiébaut R., Chêne G., Morre M., Delfraissy J. F., Enhanced T cell recovery in HIV-1-infected adults through IL-7 treatment. Journal of Clinical Investigation 2009 119 4 997 1007 2-s2.0-65249105408 10.1172/JCI38052
127. + T-regulatory cells. Journal of Immunotherapy 2006 29 3 313 319 2-s2.0-33746046073 10.1080/03601270600564088
128. Ponchel F., Cuthbert R. J., Goëb V., IL-7 and lymphopenia. Clinica Chimica Acta 2011 412 1-2 7 16 2-s2.0-78650514849 10.1016/j.cca.2010.09.002
129. Beq S., Delfraissy J. F., Theze J., Interleukin-7 (IL-7): immune function, involvement in the pathogenesis of HIV infection and therapeutic potential. European Cytokine Network 2004 15 4 279 289 2-s2.0-12344251706
130. Bolotin E., Annett G., Parkman R., Weinberg K., Serum levels of IL-7 in bone marrow transplant recipients: relationship to clinical characteristics and lymphocyte count. Bone Marrow Transplantation 1999 23 8 783 788 2-s2.0-0032946001
131. + T cell subsets expressing CD8 α α and IL-7R α in viremic, aviremic and slow progressor HIV-1-infected subjects. Clinical Immunology 2007 124 2 149 157 2-s2.0-34447322319 10.1016/j.clim.2007. 05.005
132. Napolitano L. A., Grant R. M., Deeks S. G., Schmidt D., de Rosa S. C., Herzenberg L. A., Herndier B. G., Andersson J., Mccune J. M., Increased production of IL-7 accompanies HIV-1-mediated T-cell depletion: implications for T-cell homeostasis. Nature Medicine 2001 7 1 73 79 2-s2.0-0035138982 10.1038/83381
133. Rethi B., Vivar N., Sammicheli S., Chiodi F., Limited efficiency of endogenous interleukin-7 levels in T cell reconstitution during HIV-1 infection: will exogenous interleukin-7 therapy work? AIDS 2009 23 7 745 755 2-s2.0-67649654090 10.1097/QAD.0b013e3283298572
134. + patients treated with recombinant interleukin-7. Proceedings of the 19th Conference on Retroviruses and Opportunistic Infections 2012 Seattle, Wash, USA
135. Levy Y., Sereti I., Tambussi G., Effects of rhIL-7 on T cell recovery and thymic output in HIV-infected patients receiving antiretroviral therapy: results of a phase I/IIa randomized, placebo controlled, multicenter study. Clinical Infectious Diseases 2012 55 2 291 300 10.1093/cid/cis383